Breast Cancer, Stage 3 and Stage 4

Clinical Scientific Evidence

If you’ve been diagnosed with Stage 3 breast cancer or Stage 4 metastatic breast cancer, it’s normal to feel overwhelmed—especially if treatments like chemotherapy or hormone blockers haven’t given you the results you hoped for. At CMN Hospital, we want you to know that there are still scientifically-supported options available that don’t just target the disease but help preserve your immune system’s natural strength.

One notable study from Stanford University found that women with Stage 4 breast cancer who underwent autologous stem cell treatment saw improved survival rates. The study revealed that patients who received cancer-free stem cells had a median survival of 60 months, compared to 28 months for those receiving untreated cells. While the study was focused on patients who had previously undergone chemotherapy, it showed the powerful effect that stem cell therapy can have, even in late-stage cancers.

BMT (Bone Marrow Stem Cell Therapy)

Unlike allogenic transplants, which use stem cells from a donor, autologous stem cell therapy uses the patient’s own cancer-free bone marrow stem cells. This makes it 100% compatible and reduces the risks of rejection or complications. At CMN Hospital, Dr. Payan ensures that the bone marrow is thoroughly tested to confirm there are no cancer cells present before the transplant.

The process of collecting these stem cells is simple and minimally invasive. Under sedation, a bone marrow aspiration is performed to collect the healthy stem cells, which are then prepared to support your immune system during treatment. Combined with Dendritic Cell Therapy, these stem cells help the body naturally recognize and attack cancer cells without compromising your immune defenses.

Beyond Chemotherapy

High-dose chemotherapy, while aggressive in fighting cancer, also destroys the body’s blood-forming system. This often leads to a dangerous reduction in hemoglobin levels, leaving the patient vulnerable to fatigue, infections, and other life-threatening complications. Worse, cancer cells can sometimes stow away during the transplant process, causing a relapse even after treatment.

Dr. Payan’s approach focuses on enhancing, rather than depleting, the immune system. By avoiding chemotherapy, his protocols allow the body to retain its natural blood-forming and infection-fighting capabilities, giving patients a better quality of life during treatment. Many of his patients, including those who had exhausted traditional options, have seen significant success with Dendritic Cell Therapy and Autologous Bone Marrow Stem Cell Therapy.

Autologous Bone Marrow Stem Cell Therapy: Value After Chemotherapy or Radiation

Autologous Bone Marrow Stem Cell Therapy offers a critical opportunity for patients who have undergone chemotherapy or radiation therapy. These treatments, while effective in targeting cancer, often severely compromise the immune system, reducing the body’s ability to produce healthy blood cells. By reintroducing a patient's own healthy stem cells, Autologous BMT restores this function, allowing the body to naturally regenerate red and white blood cells, as well as platelets, which are vital for fighting infections and maintaining overall health.

Since Autologous BMT uses the patient’s own cells, the risk of rejection is completely eliminated. This is a particularly valuable option for women with breast cancer who have undergone multiple rounds of chemotherapy or radiation, as their immune systems are often weakened. With Autologous BMT, the body can begin to repair itself without introducing foreign cells or substances, ensuring a safer recovery process.

Dr. Payan’s protocol at CMN Hospital focuses on enhancing the body's natural healing ability post-chemotherapy by using the patient’s own cancer-free stem cells to support long-term recovery and improve overall quality of life.

Safety and Success of Autologous Bone Marrow Stem Cell Therapy

Autologous Bone Marrow Stem Cell Therapy has been thoroughly researched and proven to be both safe and effective. Numerous studies, including those published by leading cancer research centers like the Memorial Sloan Kettering Cancer Center and Stanford University, highlight the high success rates of this treatment. These studies demonstrate that by using the patient’s own cells, the risks associated with donor transplants—such as rejection or graft-versus-host disease—are completely avoided.

In fact, research shows that patients who undergo Autologous Bone Marrow Transplantation experience improved survival rates, particularly when the therapy is used following chemotherapy or radiation. According to a study published in the journal Nature, patients saw significant recovery of their immune system and overall health following the procedure. This makes Autologous BMT a key option for patients looking for safer, more personalized treatment approaches.

By combining the body’s natural healing processes with cutting-edge medical technology, Autologous BMT offers both safety and efficacy for breast cancer patients, making it a promising option in cases where traditional treatments may have failed.

There is Hope for Breast Cancer

At CMN Hospital, we know that every breast cancer case is unique in diagnosis and staging. If you’ve been told your options are limited or you’ve exhausted chemotherapy and hormone blockers, you still have choices. Our advanced, scientifically-supported therapies offer renewed hope for patients with Stage 3 and Stage 4 metastatic breast cancer, as well as those with colon cancer, prostate cancer, and other metastatic cancers.

Take control of your health today.

Contact CMN Hospital at 1-844-371-1117